Clinic to Commercial Manufacturing: Higher Titers and Product Quality with TransIT® AAViator GMP

TransIT®-LT1 Transfection Reagent – 10 X 1.0 mL

A broad spectrum, low toxicity, DNA transfection reagent

SKU MIR 2306 Categories , Tags ,

$3,313.00

Unsure of what transfection reagent you need?
Consult Reagent AgentTM

Description

  • Broad Spectrum DNA Delivery – Utilize one transfection reagent and protocol for a variety of cells
  • Low Cellular Toxicity – Maintain cell density and reduce experimental biases  Learn more >>
  • High Efficiency Delivery – Achieve expression in a large population of cells for experimental success
  • Deliver Single or Multiple Plasmids – Suitable for applications such as virus production

 

SKU: MIR 2306

Supporting Data

 

TransIT-LT1 Transfection Reagent iPS Cells Data

 

Exceptional Transfection Efficiency in Human Induced Pluripotent Stem Cells (iPSCs) via Reverse Transfection with TransIT®-LT1. The TransIT®-LT1 Transfection Reagent was used to reverse transfect 1.3 x 106 iPS cells with a ZsGreen expressing plasmid (Clontech). Reverse transfections were performed in 6-well plates using 12 µl of TransIT®-LT1 Transfection Reagent to deliver 4 µg of DNA (3:1, reagent: DNA). Cells were visualized 48 hours post-transfection and imaged under a 10X objective with an Olympus IX71® Inverted Microscope. Images are (A) phase contrast and (B) green fluorescence. Cells were assayed 48 hours post-transfection on an Accuri® Cytometer. The histogram (C) shows untransfected cells (black line) compared to cells transfected with plasmid using TransIT®-LT1 (green line). See more information on stem cell applications.

TransIT-LT1 high efficiency transfection iCell Cardiomyocytes Fujifilm CDI data

High Efficiency Transfection of iCell® Cardiomyocytes Using TransIT®-LT1 Transfection Reagent. iCell® Cardiomyocytes were plated at 20,000 cells/well in a 96 well tissue culture plate coated with 0.1% gelatin. After allowing the cells to recover from thaw, cells were transfected with 100 ng/well of pMAXGFP (Lonza) using TransIT®-LT1 Transfection Reagent with a 2:1 reagent-to-DNA ratio according to the manufacturer’s instructions. Fluorescent images were taken 3 days post transfection using a Olympus IX71® inverted microscope. See more information on stem cell applications.

Data courtesy of
CDI logo

TransIT-LT1 Transfection Reagent HepG2 Toxicity Data

The TransIT®-LT1 Reagent Exhibits Higher Expression and Lower Cellular Toxicity Compared to Other Transfection Reagents. HepG2 cells were transfected with a luciferase expression plasmid using the designated reagents at the manufacturer’s recommended reagent-to-DNA ratio indicated beneath each bar. Transfections were performed in 96-well plates using 0.1 µg of plasmid DNA per well. Luciferase expression (bar graph) and lactate dehydrogenase (LDH) levels (line graph) were measured at 24 hours post-transfection. LDH levels are reported as % cytotoxicity compared to cells alone and were measured using a commercially available colorimetric assay; all values at or below zero are represented as zero on graph. Experiments were performed as per industry accepted testing protocols. FuGENE® is a registered trademark of Fugent LLC. Lipofectamine® is a trademark of Life Technologies Corporation.

TransIT-LT1 Transfection Reagent Competitor Summary Data

Comparable Luciferase Expression with the TransIT®-LT1 Reagent and FuGENE® 6 in Multiple Cell Types. The indicated cell lines were transfected in duplicate with 1 µg of a luciferase expression vector per well of a 12-well plate using either 3 µl of the TransIT®-LT1 or FuGENE® 6 Reagents according to industry accepted testing protocols. Cells were harvested 24 hours post-transfection and assayed for luciferase activity. FuGENE® is a registered trademark of Fugent LLC.

Resources

Specifications

Storage Conditions
All Configurations: Store at 4°C

Product Guarantee
All Configurations: 1 year

Usage Statement
All Configurations: For Research Use Only.

Animal Origin Statement
All Configurations: This product contains raw materials that are derived from animals.

Technical Product Literature

Full Protocol
TransIT®-LT1 Full Transfection Protocol (PDF)

Additional Protocol
TransIT®-LT1 for iPSC Reverse Transfection (PDF)

Quick Reference Protocol
TransIT®-LT1 Quick Ref Protocol (PDF)

SDS
TransIT®-LT1 SDS (PDF)

Optimization Protocols
Optimization Protocol for DNA Transfection (PDF)

Video Protocol
Watch Video Protocol

 

Additional Resources

Why compromise your transfection results with toxicity?
Stem cell applications
Protocol: Reverse Transfection of Human Induced Pluripotent Stem (iPS) Cells with TransIT®-LT1 Transfection Reagent (PDF)

FAQs

See the TransIT-LT1 FAQs

Using transfection reagents and enhancers from Mirus has given our platform a competitive advantage. Increasing efficiency and lowering costs for all of our programs.

Sally Mader, PhD
ZYZ Theraputics

Packaging Update Alert

We are currently transitioning to a new packaging design to ensure consistency across our product portfolio, including tube cap color. During this transition, we will continue to use existing stocks of packaging for each product line before switching to the new design. As a result, you may receive shipments containing products in either packaging configuration. We do not anticipate any impact to the quality of these products. If you have any questions or concerns, please don’t hesitate to contact our Technical Support team at mirusbio_techsupport@milliporesigma.com